Nathalie Vourc'h-Heuze

Tours, 37032, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications

Importance of the delivery route for the tolerability and efficacy of immunomodulatory agents for lung cancer.

Importance of the delivery route for the tolerability and efficacy of immunomodulatory agents for lung cancer.

Journal: Scientific reports
Published: January 22, 2026

Pseudopaline-mediated zinc uptake by Pseudomonas aeruginosa drives clinically relevant phenotypes and infection outcomes.

Pseudopaline-mediated zinc uptake by Pseudomonas aeruginosa drives clinically relevant phenotypes and infection outcomes.

Journal: Infection and immunity
Published: January 14, 2026

Excipients in orally inhaled protein formulations: current examples, challenges, and future directions.

Excipients in orally inhaled protein formulations: current examples, challenges, and future directions.

Journal: Drug discovery today
Published: November 28, 2025

Flagellin nebulization enhances respiratory immune responses in the porcine model.

Flagellin nebulization enhances respiratory immune responses in the porcine model.

Journal: iScience
Published: July 04, 2025

Exploring airway biological barriers: Implications for IgG-based therapeutics in respiratory infections.

Exploring airway biological barriers: Implications for IgG-based therapeutics in respiratory infections.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: March 06, 2025

A breath of fresh air: inhaled antibodies to combat respiratory infectious diseases - a clinical trial overview.

A breath of fresh air: inhaled antibodies to combat respiratory infectious diseases - a clinical trial overview.

Journal: Expert opinion on drug delivery
Published: December 23, 2024

Targeted delivery of flagellin by nebulization offers optimized respiratory immunity and defense against pneumococcal pneumonia.

Targeted delivery of flagellin by nebulization offers optimized respiratory immunity and defense against pneumococcal pneumonia.

Journal: Antimicrobial agents and chemotherapy
Published: October 31, 2024

Characterization of anatomical variations of the nasal cavity in a subset of European patients and their impact on intranasal drug delivery.

Characterization of anatomical variations of the nasal cavity in a subset of European patients and their impact on intranasal drug delivery.

Journal: International journal of pharmaceutics
Published: August 28, 2024

Synergy between Lactobacillus murinus and anti-PcrV antibody delivered in the airways to boost protection against Pseudomonas aeruginosa.

Synergy between Lactobacillus murinus and anti-PcrV antibody delivered in the airways to boost protection against Pseudomonas aeruginosa.

Journal: Molecular therapy. Methods & clinical development
Published: December 14, 2023

Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.

Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.

Journal: The New England journal of medicine
Published: October 27, 2023

The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodies.

The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodies.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: October 18, 2023

Barriers for orally inhaled therapeutic antibodies.

Barriers for orally inhaled therapeutic antibodies.

Journal: Expert opinion on drug delivery
Published: August 23, 2023
Showing 1-12 of 68

Last Updated: 09/26/2026